Osaic Holdings’s Intelligent Bio Solutions INBS Stock Holding History

Osaic Holdings’s Portfolio INBS Stock Details INBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$460	Hold	200	–	–	﹤0.01%	7666
2026 Q1	$670	Buy	+200	New	+$1.38K	﹤0.01%	7374

Other funds holding INBS

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Osaic Holdings's INBS Position: Q2 2026 in Review

Osaic Holdings held its Intelligent Bio Solutions (INBS) position steady in Q2 2026 at 200 shares worth $460. The position accounts for ﹤0.01% of the portfolio, ranked #7666.

Osaic Holdings first reported a position in INBS in Q1 2026 and has held it in 2 quarters since. The position peaked at $670 in Q1 2026. 8 funds tracked by Wall St. Rank hold INBS as of Q2 2026.

Osaic Holdings held 200 shares of Intelligent Bio Solutions worth $460 as of Q2 2026.
Osaic Holdings left its Intelligent Bio Solutions share count unchanged in Q2 2026.
Intelligent Bio Solutions made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7666 holding.
Osaic Holdings first reported a position in Intelligent Bio Solutions in Q1 2026 and has held it in 2 quarters since.
Osaic Holdings's Intelligent Bio Solutions position peaked at $670 in Q1 2026.
8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.